{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:54:08Z","timestamp":1791536048604,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05540-1","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:17:05Z","timestamp":1781237825000},"page":"18861-18871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical evaluation of adjunctive magnesium therapy in patients receiving antidepressants for depression\u2014open label, nonrandomized clinical trial"],"prefix":"10.1007","volume":"399","author":[{"given":"Afifa","family":"Siddique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Masood","family":"Khokhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushayada","family":"Irshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayaba","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sughra","family":"Kanwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"10","key":"5540_CR1","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1080\/1028415X.2021.1945859","volume":"25","author":"B Abiri","year":"2022","unstructured":"Abiri B, Sarbakhsh P, Vafa M (2022) Randomized study of the effects of vitamin D and\/or magnesium supplementation on mood, serum levels of BDNF, inflammation, and SIRT1 in obese women with mild to moderate depressive symptoms. Nutr Neurosci 25(10):2123\u20132135","journal-title":"Nutr Neurosci"},{"key":"5540_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.clnesp.2020.12.022","volume":"42","author":"M Afsharfar","year":"2021","unstructured":"Afsharfar M, Shahraki M, Shakiba M, Asbaghi O, Dashipour A (2021) The effects of magnesium supplementation on serum level of brain derived neurotrophic factor (BDNF) and depression status in patients with depression. Clin Nutr ESPEN 42:381\u2013386","journal-title":"Clin Nutr ESPEN"},{"key":"5540_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101171","volume":"41","author":"F Alemi","year":"2021","unstructured":"Alemi F, Min H, Yousefi M, Becker LK, Hane CA, Nori VS et al (2021) Effectiveness of common antidepressants: a post market release study. EClinicalMedicine 41:101171","journal-title":"EClinicalMedicine"},{"key":"5540_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080821","author":"MA Alvarez-Mon","year":"2021","unstructured":"Alvarez-Mon MA, Ortega MA, Garcia-Montero C, Fraile-Martinez O, Monserrat J, Lahera G et al (2021) Exploring the role of nutraceuticals in major depressive disorder (MDD): rationale, state of the art and future prospects. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph14080821","journal-title":"Pharmaceuticals (Basel)"},{"key":"5540_CR5","unstructured":"Amerio A, Aguglia A, Odone A, Gianfredi V, Serafini G, Signorelli C, et al (2020) Covid-19 pandemic impact on mental health of vulnerable populations. Acta Biomed 91(9-s):95\u20136"},{"key":"5540_CR6","unstructured":"Bains N, Abdijadid S (2023) Major depressive disorder. StatPearls. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559078\/#:~:text=Major%20depressive%20disorder%20(MDD)%20has,will%20rank%20first%20by%202030. Accessed 3 Dec 2025"},{"issue":"2","key":"5540_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/nu13020463","volume":"13","author":"M Barbagallo","year":"2021","unstructured":"Barbagallo M, Veronese N, Dominguez LJ (2021) Magnesium in aging, health and diseases. Nutrients 13(2):463","journal-title":"Nutrients"},{"key":"5540_CR8","unstructured":"Brown MJ, Sharma P, Mir FA, Bennett PN (2018) Clinical pharmacology, 12th edn. Elsevier"},{"key":"5540_CR9","unstructured":"Brunton LL, Knollmann BC, Hilal-Dandan R (2018) Goodman & Gilman\u2019s: the pharmacological basis of therapeutics, 13 edn. McGraw-Hill Education, New York"},{"key":"5540_CR10","volume":"45","author":"AT Caliman-Fontes","year":"2023","unstructured":"Caliman-Fontes AT, Leal GC, Correia-Melo FS, Paixao CS, Carvalho MS, Jesus-Nunes AP et al (2023) Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial. Trends Psychiatry Psychother 45:e20210298","journal-title":"Trends Psychiatry Psychother"},{"issue":"1","key":"5540_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/13651501.2019.1699575","volume":"24","author":"D De Berardis","year":"2020","unstructured":"De Berardis D, Vellante F, Fornaro M, Anastasia A, Olivieri L, Rapini G et al (2020) Alexithymia, suicide ideation, affective temperaments and homocysteine levels in drug na\u00efve patients with post-traumatic stress disorder: an exploratory study in the everyday \u201creal world\u201d clinical practice. Int J Psychiatry Clin Pract 24(1):83\u201387","journal-title":"Int J Psychiatry Clin Pract"},{"key":"5540_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ibneur.2021.06.002","volume":"11","author":"M Ekong","year":"2021","unstructured":"Ekong M, Iniodu C (2021) Nutritional therapy can reduce the burden of depression management in low income countries: a review. IBRO Neurosci Rep 11:15\u201328","journal-title":"IBRO Neurosci Rep"},{"issue":"7","key":"5540_CR13","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.neuron.2025.01.021","volume":"113","author":"X Huang","year":"2025","unstructured":"Huang X, Sun X, Wang Q, Zhang J, Wen H, Chen WJ et al (2025) Structural insights into the diverse actions of magnesium on NMDA receptors. Neuron 113(7):1006\u201318.e4","journal-title":"Neuron"},{"key":"5540_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jad.2020.11.066","volume":"281","author":"S Hudgens","year":"2021","unstructured":"Hudgens S, Floden L, Blackowicz M, Jamieson C, Popova V, Fedgchin M et al (2021) Meaningful change in depression symptoms assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-\u00c5sberg Depression Rating Scale (MADRS) among patients with treatment resistant depression in two, randomized, double-blind, active-controlled trials of esketamine nasal spray combined with a new oral antidepressant. J Affect Disord 281:767\u2013775","journal-title":"J Affect Disord"},{"issue":"4","key":"5540_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/bmjebm-2019-111238","volume":"25","author":"JC Jakobsen","year":"2020","unstructured":"Jakobsen JC, Gluud C, Kirsch I (2020) Should antidepressants be used for major depressive disorder? BMJ Evid Based Med 25(4):130","journal-title":"BMJ Evid Based Med"},{"issue":"1","key":"5540_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/TPSY.TPSY_8_20","volume":"34","author":"A Javed","year":"2020","unstructured":"Javed A, Khan MNS, Nasar A, Rasheed A (2020) Mental healthcare in Pakistan. Taiwan J Psychiatry 34(1):6\u201314","journal-title":"Taiwan J Psychiatry"},{"issue":"1","key":"5540_CR17","first-page":"41","volume":"15","author":"M Khokhar","year":"2020","unstructured":"Khokhar M, Masood S, Muneer A, Waheed U, Aftab F, Bibi I (2020) Medication non-adherence in anxiety and depression. J Islam Int Med Coll (JIIMC) 15(1):41\u201345","journal-title":"J Islam Int Med Coll (JIIMC)"},{"issue":"10161","key":"5540_CR18","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"GS Malhi","year":"2018","unstructured":"Malhi GS, Mann JJ (2018) Depression. Lancet 392(10161):2299\u20132312","journal-title":"Lancet"},{"key":"5540_CR19","volume":"2011","author":"LM Mart\u00edn-L\u00f3pez","year":"2011","unstructured":"Mart\u00edn-L\u00f3pez LM, Rojo JE, Gibert K, Mart\u00edn JC, Sperry L, Du\u00f1\u00f3 L et al (2011) The strategy of combining antidepressants in the treatment of major depression: clinical experience in spanish outpatients. Depress Res Treat 2011:140194","journal-title":"Depress Res Treat"},{"issue":"5","key":"5540_CR20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10534-021-00328-7","volume":"34","author":"AA Mathew","year":"2021","unstructured":"Mathew AA, Panonnummal R (2021) \u2018Magnesium\u2019-the master cation-as a drug-possibilities and evidences. Biometals 34(5):955\u2013986","journal-title":"Biometals"},{"issue":"2","key":"5540_CR21","first-page":"001857872513845","volume":"61","author":"M Memon","year":"2025","unstructured":"Memon M, Gul R, Gul A, Bansari S, Bansari M, Khowaja A et al (2025) Esketamine for treatment-resistant depression in Pakistan: a promising strategy. Hosp Pharm 61(2):00185787251384516","journal-title":"Hosp Pharm"},{"key":"5540_CR22","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.21m13988","author":"R Mojtabai","year":"2021","unstructured":"Mojtabai R, Amin-Esmaeili M, Spivak S, Olfson M (2021) Remission and treatment augmentation of depression in the United States. J Clin Psychiatry. https:\/\/doi.org\/10.4088\/JCP.21m13988","journal-title":"J Clin Psychiatry"},{"key":"5540_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yhbeh.2018.07.003","volume":"105","author":"J Petrovi\u0107","year":"2018","unstructured":"Petrovi\u0107 J, Stani\u0107 D, Bulat Z, Pu\u0161ka\u0161 N, Labudovi\u0107-Borovi\u0107 M, Batini\u0107 B et al (2018) Acth-induced model of depression resistant to tricyclic antidepressants: neuroendocrine and behavioral changes and influence of long-term magnesium administration. Horm Behav 105:1\u201310","journal-title":"Horm Behav"},{"key":"5540_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.nut.2016.10.014","volume":"35","author":"A Rajizadeh","year":"2017","unstructured":"Rajizadeh A, Mozaffari-Khosravi H, Yassini-Ardakani M, Dehghani A (2017) Effect of magnesium supplementation on depression status in depressed patients with magnesium deficiency: a randomized, double-blind, placebo-controlled trial. Nutrition 35:56\u201360","journal-title":"Nutrition"},{"issue":"7","key":"5540_CR25","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1007\/s00394-022-02916-w","volume":"61","author":"A Rosanoff","year":"2022","unstructured":"Rosanoff A, West C, Elin RJ, Micke O, Baniasadi S, Barbagallo M et al (2022) Recommendation on an updated standardization of serum magnesium reference ranges. Eur J Nutr 61(7):3697\u20133706","journal-title":"Eur J Nutr"},{"key":"5540_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020400","author":"JD Rosenblat","year":"2023","unstructured":"Rosenblat JD, de Vries FE, Doyle Z, McIntyre RS, Rodin G, Zimmermann C et al (2023) A phase II, open-label clinical trial of intranasal ketamine for depression in patients with cancer receiving palliative care (INKeD-PC Study). Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15020400","journal-title":"Cancers (Basel)"},{"issue":"8","key":"5540_CR27","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/nu10081014","volume":"10","author":"B Ryszewska-Pokrasniewicz","year":"2018","unstructured":"Ryszewska-Pokrasniewicz B, Mach A, Skalski M, Januszko P, Wawrzyniak ZM, Poleszak E et al (2018) Effects of magnesium supplementation on unipolar depression: a placebo-controlled study and review of the importance of dosing and magnesium status in the therapeutic response. Nutrients 10(8):1014","journal-title":"Nutrients"},{"key":"5540_CR28","unstructured":"Sheffler ZM, Patel P, Abdijadid S (2023) Antidepressants. StatPearls. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538182\/. Accessed 3 Dec 2025"},{"issue":"1","key":"5540_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40360-025-00846-x","volume":"26","author":"A Siddique","year":"2025","unstructured":"Siddique A, Khokhar MM, Waheed A, Naeem U, Aziz SA (2025a) Effect of combination therapy of methylfolate with antidepressants in patients with depressive disorder. BMC Pharmacol Toxicol 26(1):14","journal-title":"BMC Pharmacol Toxicol"},{"issue":"2","key":"5540_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.62438\/tunismed.v103i2.5280","volume":"103","author":"A Siddique","year":"2025","unstructured":"Siddique A, Naeem U, MasoodKhokhar M, Waheed Syed A, Iftikhar J, Amjad A (2025b) Impact of demographic factors on the treatment response of antidepressant therapy: a descriptive cohort study from Pakistan. Tunis Med 103(2):201\u2013205","journal-title":"Tunis Med"},{"issue":"14","key":"5540_CR31","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.3390\/jcm10143135","volume":"10","author":"M Skalski","year":"2021","unstructured":"Skalski M, Mach A, Januszko P, Ryszewska-Pokrasniewicz B, Biernacka A, Nowak G et al (2021) Pharmaco-electroencephalography-based assessment of antidepressant drug efficacy-the use of magnesium ions in the treatment of depression. J Clin Med 10(14):3135","journal-title":"J Clin Med"},{"issue":"Suppl 11","key":"5540_CR32","first-page":"S454","volume":"63","author":"KL Smarr","year":"2011","unstructured":"Smarr KL, Keefer AL (2011) Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res (Hoboken) 63(Suppl 11):S454\u2013S466","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"5540_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180067","volume":"12","author":"EK Tarleton","year":"2017","unstructured":"Tarleton EK, Littenberg B, MacLean CD, Kennedy AG, Daley C (2017) Role of magnesium supplementation in the treatment of depression: a randomized clinical trial. PLoS ONE 12(6):e0180067","journal-title":"PLoS ONE"},{"issue":"3","key":"5540_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.156","volume":"3","author":"H Tian","year":"2020","unstructured":"Tian H, Hu Z, Xu J, Wang (2020) The molecular pathophysiology of depression and the new therapeutics. MedComm (2020) 3(3):e156","journal-title":"MedComm (2020)"},{"issue":"38","key":"5540_CR35","doi-asserted-by":"publisher","first-page":"9817","DOI":"10.1523\/JNEUROSCI.3038-15.2016","volume":"36","author":"AK Toft","year":"2016","unstructured":"Toft AK, Lundbye CJ, Banke TG (2016) Dysregulated NMDA-receptor signaling inhibits long-term depression in a mouse model of fragile X syndrome. J Neurosci 36(38):9817\u20139827","journal-title":"J Neurosci"},{"issue":"8","key":"5540_CR36","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1177\/02698811211013579","volume":"35","author":"GH V\u00e1zquez","year":"2021","unstructured":"V\u00e1zquez GH, Bahji A, Undurraga J, Tondo L, Baldessarini RJ (2021) Efficacy and tolerability of combination treatments for major depression: antidepressants plus second-generation antipsychotics vs. esketamine vs. lithium. J Psychopharmacol 35(8):890\u2013900","journal-title":"J Psychopharmacol"},{"issue":"1","key":"5540_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13033-022-00539-6","volume":"16","author":"DV Vigo","year":"2022","unstructured":"Vigo DV, Kazdin AE, Sampson NA, Hwang I, Alonso J, Andrade LH et al (2022) Determinants of effective treatment coverage for major depressive disorder in the WHO World Mental Health Surveys. Int J Ment Health Syst 16(1):29","journal-title":"Int J Ment Health Syst"},{"key":"5540_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jad.2022.11.072","volume":"323","author":"H Wang","year":"2023","unstructured":"Wang H, Jin M, Xie M, Yang Y, Xue F, Li W et al (2023) Protective role of antioxidant supplementation for depression and anxiety: a meta-analysis of randomized clinical trials. J Affect Disord 323:264\u2013279","journal-title":"J Affect Disord"},{"key":"5540_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaf056","author":"G Yoon","year":"2025","unstructured":"Yoon G, Pittman B, Ralevski E, Petrakis IL, Krystal JH (2025) Antidepressant efficacy of ketamine plus naltrexone for major depression comorbid with alcohol use disorder: a randomized controlled trial. Int J Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyaf056","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"5540_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/anae.12107","volume":"68","author":"AA Yousef","year":"2013","unstructured":"Yousef AA, Al-deeb AE (2013) A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component. Anaesthesia 68(3):260\u2013266","journal-title":"Anaesthesia"},{"key":"5540_CR41","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fphar.2018.00862","volume":"9","author":"L Zhen","year":"2018","unstructured":"Zhen L, Shao T, Luria V, Li G, Li Z, Xu Y et al (2018) EphB2 deficiency induces depression-like behaviors and memory impairment: involvement of NMDA 2B receptor dependent signaling. Front Pharmacol 9:862","journal-title":"Front Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05540-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:43:18Z","timestamp":1791535398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05540-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5540"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05540-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol received institutional review board approval and that all participants provided informed consent in the format required by the relevant authorities and\/or boards (Prof. Dr. Maqsood ul Hassan, Dr. Uzma Naeem, Dr. Muhammad Masood Khokhar, Dr. Shabana Ali, and Dr. Ayyaz Bhatti (Riphah\/IIMC\/IRC\/22\/2079)).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}